Drug use and treatment misuse: Key points on polydrug use
Drug use and treatment misuse: Key points on polydrug use
复制标题
DOI：
10.1016/j.lpm.2016.10.010
复制
发表时间：
2016-12-01
期刊：
影响因子：
2.7
通讯作者：
Touzeau, Didier
中科院分区：
文献类型：
--
作者：
Deschenau, Alice;Iftimovici, Anton;Touzeau, Didier
有问题地使用精神活性药物，无论是法律的、处方的还是非处方的，从整体上看仍然是一个广泛的现象，使用的产品范围越来越大。多毒品使用是一个不断扩大的新趋势。虽然其流行病学分析很复杂，需要进一步研究，但可以发现某些药物组合模式，从而可以确定与更具体的医疗和社会风险相关的使用者群体。管理多种药物使用者包括评估每种药物的使用，以及药物与患者对每种药物的期望之间的联系。应考虑并发症以及精神和躯体共病。多物质药物使用的治疗工具，主要是药理学，仍然往往限于每种产品的具体工具的总和。预防至关重要，但必须适应已确定的使用群组和性别。值得注意的是，需要充分了解慢性疼痛管理和处方药物依赖风险，以防止涉及类阿片的多种物质药物使用。
Problematic use of psychoactive drugs, be it legal, on prescription, or not, remains a broad phenomenon when taken as a whole, with an increasingly large spectrum of used products. The polysubstance drug use is an expanding new trend. Although its epidemiological analysis is complex, needing further research, certain patterns of drug combinations can be found, allowing to identify clusters of users associated to more specific medical and social risks. Managing polysubstance users involves assessing each drug use, but also the connections between drugs and the patient's expectations for each of them. Complications, as well as psychiatric and somatic comorbidities are to be taken into account. The therapeutic tools for polysubstance drug use, mainly pharmacological, are still often limited to the sum of specific tools for each product. Prevention is crucial but has to adapt to the identified use clusters, and the gender. Notably, a good knowledge of chronic pain management and prescribed drug dependency risks is required to prevent polysubstance drug use involving opioids.